These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2150504)

  • 1. [Goserelin depot: an analog of LHRH for the treatment of endometriosis].
    Shaw RW
    Drugs Exp Clin Res; 1990; 16 Suppl():69-75. PubMed ID: 2150504
    [No Abstract]   [Full Text] [Related]  

  • 2. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
    Shaw RW
    Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
    Shaw RW
    Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL; Cetera C; de Laurentiis G
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
    Stevenson JC; Lees B; Gardner R; Shaw RW
    Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
    Reichel RP; Schweppe KW
    Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale in use of LHRH analogues in endometriosis.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of LHRH agonist therapy in the treatment of endometriosis (English experience).
    Jelley RY; Magill PJ
    Prog Clin Biol Res; 1986; 225():227-38. PubMed ID: 3097668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
    Yee B
    Prog Clin Biol Res; 1986; 225():175-88. PubMed ID: 3097664
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
    Golland IM; Vaughan-Williams CA; Shalet SM; Laing I; Elstein M
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):405-10. PubMed ID: 2146853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
    Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
    Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
    [No Abstract]   [Full Text] [Related]  

  • 13. LHRH analogue for treatment of recurrent and refractory mastalgia.
    Hamed H; Caleffi M; Chaudary MA; Fentiman IS
    Ann R Coll Surg Engl; 1990 Jul; 72(4):221-4. PubMed ID: 2143364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
    Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
    Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with the LH-RH agonist (Zoladex depot) in patients with puberty praecox].
    Bassi F; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():33-7. PubMed ID: 2150502
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY; Spellacy WN; Dmowski WP; Gambrell RD; Greenblatt RB; Girard Y; Lemay A; Mishell DR; Nagamani M; Pepperell RJ
    Prog Clin Biol Res; 1990; 323():253-67. PubMed ID: 2106142
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
    Lemay A; Brideau NA; Forest JC; Dodin S; Maheux R
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience.
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):55-60. PubMed ID: 8775253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical appreciation of LHRH analogue formulations.
    Lemay A
    Horm Res; 1989; 32 Suppl 1():93-101; discussion 102. PubMed ID: 2533161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
    Lemay A; Maheux R; Jean C; Faure N
    Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.